Trial Profile

Study to Evaluate Synovial Fluid in the Phase 3 Fasinumab Program for Osteoarthritis of the Knee and Hip

Status: Recruiting

Phase of Trial: Phase III

Latest Information Update: 15 Jul 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Fasinumab (Primary) ; Celecoxib; Diclofenac; Naproxen
Indications Pain
Focus Biomarker; Registrational; Therapeutic Use
Sponsors Regeneron Pharmaceuticals

Most Recent Events

15 Jul 2020 This trial has been discontinued in United kingdom, according to European Clinical Trials Database record.
14 Jun 2019 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com